Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
- Roche has announced the launch of the Roche Genentech Innovation Center in Allston, Massachusetts at Harvard's Enterprise Research Campus, aiming to enhance research in cardiovascular, renal, and metabolic diseases.
- Manu Chakravarthy will lead the new center, which could eventually employ up to 500 people, according to Roche's announcement.
- The center will function as a hub for Roche's drug discovery efforts, utilizing expertise in AI and data science, with initial construction set to complete in 2026.
- Roche CEO Thomas Schinecker emphasized the importance of this center for research collaboration and talent leverage in the Boston area.
9 Articles
9 Articles
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an Innovation Center on Harvard’s Enterprise Research Campus in Allston. The Swiss multinational company is leasing 30,000 square feet of space from the ERC’s 1.9 million square feet,and plans to eventually employ up to 500 employees.
Brigham Young University Adopts Genetec Operations Center
Genetec, a unified security, public safety, operations, and business intelligence solutions provider, announced Brigham Young University's (BYU) has enhanced its security operations with the Genetec™ Operations Center work management system. Located on a 560-acre campus in Provo, Utah, BYU is home to nearly 34,000 students and over 5,000 faculty and staff. The university’s security program includes 25 sworn officers, 15 security supervisors, and…
Roche Genentech Innovation Center Boston Launched at Harvard’s Enterprise Research Campus
The Roche Genentech Innovation Center Boston has been launched at Harvard’s Enterprise Research Campus in Allston, MA. Roche officials say the move will further strengthen the partnership in areas such as disease biology, engineering, and artificial intelligence/machine learning. The Center will serve as Roche’s Cardiovascular, Renal, and Metabolism (CVRM) hub that will also support some of Roche’s and Genentech’s efforts in AI and data science …
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage